Korea Pharmaceutical Bio Association holds KPBMA Ethics Management Workshop in the first half of 2025

Jun 02, 2025

Korea Pharmaceutical Bio Association holds KPBMA Ethics Management Workshop in the first half of 2025



On the 30th of last month, the Korea Pharmaceutical and Biological Association held a 'KPBMA Ethics Management Workshop' at the Korea Science and Technology Center to establish a sound drug distribution order and strengthen ethical management in the pharmaceutical and biological industry.

The workshop, attended by more than 500 people in charge of compliance (CP) in the pharmaceutical industry, ▲ Preparation and disclosure of expenditure reports (Ahn Mi-sun, team leader of the Health Insurance Review and Assessment Service's Distribution Order Management Division) ▲ Issues and countermeasures related to the tax audit by the National Tax Service (lawyer Yulchon Chae Joo-yup, tax accountant Shin Jae-wan) ▲ Recent trend of government investigations into the pharmaceutical industry (lawyers for Kang Han-cheol, Lee Hwan-beom, and Kang In-je at Kim & Chang's law firm) ▲ Trends in policies to prevent unfair transactions.

Roh Yeon-hong, president of the Korea Pharmaceutical and Bio Association, said in his opening speech that `Since the enactment of the Fair Competition Covenant in 1994, the association has taken the lead in practicing ethical management'\`I hope this workshop will serve as a valuable foundation for establishing drug distribution order and creating a mature compliance environment.'




Reporter Kim So-hyung compact@sportschosun.com



This article was translated by Naver AI translator.